awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q53828883-14521D31-2E4B-48FC-A2DA-413AC249EE99
Q53828883-14521D31-2E4B-48FC-A2DA-413AC249EE99
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53828883-14521D31-2E4B-48FC-A2DA-413AC249EE99
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 Inhibition.
P2860
Q53828883-14521D31-2E4B-48FC-A2DA-413AC249EE99
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53828883-14521D31-2E4B-48FC-A2DA-413AC249EE99
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eaf9323e5821815ee9043745a4d488cddc9b111c
P2860
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).